We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bone Resorption, Osteoclastogenesis and Adalimumab (BROCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00814866
Recruitment Status : Completed
First Posted : December 25, 2008
Last Update Posted : October 27, 2016
Information provided by (Responsible Party):
Artur de Brum-Fernandes, Université de Sherbrooke

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2010
  Study Completion Date : March 2011